| Product Name | MF | CAS | Details |
|---|
| RUNX-IN-2 | C71H88Cl2N24O11 | 2893777-88-1 | Details |
| Topoisomerase II inhibitor 15 | 451516-79-3 | Details |
| Tuberculosis inhibitor 6 | C21H19N3O2S | 121041-08-5 | Details |
| Tuberculosis inhibitor 7 | C21H18FN3O2S | 121041-20-1 | Details |
| HL23 | C44H44N2O7 | 1448355-15-4 | Details |
| CBP/p300-IN-21 | C19H16NO4.Cl | 1065581-69-2 | Details |
| M867 | C27H43N7O6 | 680999-39-7 | Details |
| mTOR inhibitor-11 | C21H26N6O2 | 3033409-32-1 | Details |
| RSV L-protein-IN-2 | C32H36N4O5 | 774130-99-3 | Details |
| FEN1-IN-6 | C12H8N2O5S2 | 824983-84-8 | Details |
| Homouridine | C10H14N2O6 | 30685-57-5 | Details |
| Orexin receptor modulator-1 | 2125735-57-9 | Details |
| ATR-IN-29 | C19H22N8O | 2761193-67-1 | Details |
| JAK1-IN-11 | C26H36N6O4S | 2427608-43-1 | Details |
| PROTAC IRAK4 degrader-8 | C43H50ClF2N11O5 | 2911615-06-8 | Details |
| MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | C63H91N9O16 | 1609108-96-4 | Details |
| Estrogen receptor modulator 8 | 2170766-56-8 | Details |
| THR-β modulator-1 | 2770373-00-5 | Details |
| HDAC8-IN-4 | C17H14N2O2S2 | 1600528-05-9 | Details |
| Estrogen receptor modulator 7 | 2639168-13-9 | Details |
| MOR agonist-1 | C22H26ClFN2O2 | 2305781-14-8 | Details |
| ER degrader 7 | 2922929-63-1 | Details |
| ER degrader 6 | 2922929-62-0 | Details |
| CDD-1819 | 2894104-40-4 | Details |
| IACS-52825 | C16H13F7N4O2 | 2640376-72-1 | Details |
| DPP | C36H40Cl2N2O10Pt | 2668267-47-6 | Details |
| STAT3-IN-18 | C18H24Cl2N2O6Pt | 2668267-41-0 | Details |
| RUNX-IN-1 | C71H88Cl2N24O11 | 2177285-35-5 | Details |
| KRAS degrader-1 | C55H57Br2ClFIN8O7 | 2795275-59-9 | Details |
| PD-1/PD-L1-IN-34 | 2924403-17-6 | Details |
| Anticancer agent 128 | 2941243-62-3 | Details |
| NWP-0476 | C47H53ClN8O8S | 2290611-26-4 | Details |
| 6-Iodoamiloride | C6H8IN7O | 60398-23-4 | Details |
| RSV L-protein-IN-5 | 851658-28-1 | Details |
| CDD-1733 | 2894104-33-5 | Details |
| CDD-1845 | C34H31N5O2 | 2894104-50-6 | Details |
| WM-586 | C20H20F3N5O3S | 2894832-05-2 | Details |
| BTK-IN-25 | 2562351-92-0 | Details |
| CDK4/6-IN-17 | C27H28F4N8 | 2035069-96-4 | Details |
| Antitumor agent-114 | 2757762-91-5 | Details |
| ATR-IN-22 | C25H31N7O | 2905312-07-2 | Details |
| PCSK9-IN-14 | C15H10F6N4O2 | 2913198-84-0 | Details |
| Anticancer agent 127 | C26H37FN4O6S | 2410953-19-2 | Details |
| Bcl-2-IN-11 | C45H49ClFN7O8S | 2760536-88-5 | Details |
| AMPA receptor modulator-5 | C20H12F4N6 | 2034182-22-2 | Details |
| TMV-IN-5 | C22H23N3S | 1207318-92-0 | Details |
| RSV L-protein-IN-3 | 868860-35-9 | Details |
| CT1113 | C25H29N5O2S | 2523435-18-7 | Details |
| 1-Isopropyltryptophan | 1219485-46-7 | Details |
| PI3Kδ-IN-13 | 1686137-02-9 | Details |
| DQn-1 | C16H14ClN5O2 | 57343-54-1 | Details |
| DQP-26 | C28H21Cl2N3O4 | 1449373-99-2 | Details |
| PCSK9-IN-15 | 2455423-94-4 | Details |
| PPARγ agonist 8 | 1049800-41-0 | Details |
| SDH-IN-3 | C15H11F2N3OS | 2805297-11-2 | Details |
| CDK4-IN-2 | 2380320-68-1 | Details |
| TRPC3/6-IN-2 | 2387893-55-0 | Details |
| PRMT5-IN-28 | C18H19ClN4O5 | 2242753-66-6 | Details |
| G43-C3-TEG | 2702262-15-3 | Details |
| SP-2-225 | C28H34N2O3 | 2364448-93-9 | Details |
| Y18501 | 2410627-32-4 | Details |
| IIIM-8 | C14H17NO4 | 1128053-62-2 | Details |
| ROCK-IN-7 | C17H17N3O2S | 2376635-95-7 | Details |
| JAK1-IN-10 | 2416858-88-1 | Details |
| KRAS G12D modulator-1 | 2883034-05-5 | Details |
| JAK-IN-27 | C20H21F2N7O | 2673176-36-6 | Details |
| Anticancer agent 121 | 2924532-47-6 | Details |
| Immuno modulator-1 | C32H31FN6O4 | 2757469-20-6 | Details |
| DNA-PK-IN-10 | C25H28N6O2 | 2919315-89-0 | Details |
| GLX481304 | C23H29N7O | 701224-63-7 | Details |
| YXG-158 | C30H36FN3O | 2952994-34-0 | Details |
| BT424 | C22H15BCl2N2O2 | 2755180-37-9 | Details |
| 3′-Acetate-ATP | C12H18N5O14P3 | 90290-58-7 | Details |
| CFTR corrector 12 | C19H21ClN4O2S2 | 958941-60-1 | Details |
| Sirt1/2-IN-2 | C18H14N4O3S2 | 670267-73-9 | Details |
| GPR119 agonist 2 | C23H24FN5O4S2 | 1384951-03-4 | Details |
| AMPA receptor modulator-6 | C24H36N2O4S2 | 516491-33-1 | Details |
| Syk-IN-8 | C23H26N10 | 2568963-01-7 | Details |
| DCLK1-IN-2 | C26H32N8O3S | 2978517-43-8 | Details |
| FD1024 | C21H20F2N4O2S | 1422456-47-0 | Details |
| Tuberculosis inhibitor 8 | C21H19FN4O | 141353-07-3 | Details |
| Antifungal agent 66 | 1613152-33-2 | Details |
| Antibacterial agent 154 | 2163048-45-9 | Details |
| Antitumor agent-104 | C31H33FN6O3 | 2245272-16-4 | Details |
| TRV-1387 | C23H25F3N4O2 | 1569645-63-1 | Details |
| MK-8768 | C21H22F3N5O2 | 1432729-22-0 | Details |
| AXL-IN-15 | 1954722-22-5 | Details |
| SARS-CoV-2-IN-43 | C16H12O3 | 31356-11-3 | Details |
| Antitrypanosomal agent 14 | C14H23N3OS | 1447933-37-0 | Details |
| USP7-IN-12 | C29H28ClFN4O2S | 2763698-01-5 | Details |
| Anticancer agent 122 | C18H15ClN2O2S | 2924532-50-1 | Details |
| RET-IN-24 | C27H26F2N8O | 2583767-68-2 | Details |
| ATR-IN-21 | C23H27N7O | 2905312-17-4 | Details |
| CDK9-IN-23 | C22H25ClN4O3 | 2761572-96-5 | Details |
| PROTAC KRAS G12C degrader-3 | C63H75ClN14O6 | 2768099-51-8 | Details |
| Hedgehog IN-2 | 1126365-74-9 | Details |
| 22-(4′-py)-JA | 1178895-15-2 | Details |
| BI 7446 | C20H22FN9O10P2S2 | 2767011-00-5 | Details |
| Leucettinib-92 | C21H22N4OS | 2732859-57-1 | Details |
| HIV-1 protease-IN-9 | 2925381-27-5 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 | ||||